TickerFacts.

YD Bio Ltd (YDES): Revenue

Annual figures by period end, from SEC filings.

$596.8K
Year ended 2025-12-31
2023-12-31: $350.1K2024-12-31: $510.4K2025-12-31: $596.8K$596.8K
2023-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$596.8K+16.9%2026-04-30, From 2025-01-01
2024-12-31$510.4K+45.8%2026-04-30, From 2024-01-01
2023-12-31$350.1Kn/a2026-04-30, From 2023-01-01

Revenue at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
YD Bio Ltd (YDES)2025-12-31$596.8K+16.9%
Sera Prognostics, Inc. (SERA)2025-12-31$81.0K+5.2%
Aclarion, Inc. (ACON)2025-12-31$75.7K+65.6%
BioNexus Gene Lab Corp (BGLC)2025-12-31$7.42M-21.9%
American Shared Hospital Services (AMS)2025-12-31$28.08M-0.9%
CapForce Inc. (CFOR)2025-12-31$30.20M+481.2%
Exagen Inc. (XGN)2025-12-31$66.58M+19.7%
Personalis, Inc. (PSNL)2025-12-31$69.65M-17.7%
Biodesix Inc (BDSX)2025-12-31$88.50M+24.1%

Compare YDES, SERA, ACON, BGLC side by side · Screen every company in Services-Medical Laboratories ↗